New AMH testing insights offer better monitoring for menopause transition

Researchers have developed a new age-specific reference table for Anti-Müllerian hormone (AMH) to better monitor ovarian reserve in women aged 35 to 55. Led by Professor Yingying Qin of Shandong University and Professor Ruimin Zheng of the National Center for Women and Children's Health, the study utilized an ultrasensitive AMH assay to provide more precise measurements during the perimenopausal transition, particularly for women aged 44 to 49.

This new clinical tool allows healthcare providers to compare a woman's AMH levels against an age-calibrated coordinate map to determine if her ovarian reserve is progressing normally or lagging behind her peers. The findings were published in the Chinese Medical Journal.

In addition to clinical monitoring, experts emphasize lifestyle management for menopause symptoms. Dietary adjustments, including consuming foods high in healthy fats, fiber, antioxidants, and phytoestrogens, may help mitigate symptoms such as hot flashes and insomnia. Other recommended strategies include regular exercise, meditation, and hormone replacement therapy to manage the significant decline in estrogen levels.